Financials

News Ideas Minds Forecast

DUL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Alnylam Pharmaceuticals Inc.

Total assets of DUL for Q1 24 is 3.54 B EUR, 2.15% more than the previous Q4 23. And total liabilities increased by 2.12% in Q1 24 to 3.75 B EUR.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—